Trials / Unknown
UnknownNCT02807935
The in Vivo Effect of Medical and Surgical Glaucoma Treatments on the Schlemm's Canal Micro-structure
The in Vivo Effect of Medical and Surgical Glaucoma Treatments on the Schlemm's Canal
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 440 (estimated)
- Sponsor
- Sheba Medical Center · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of our current series of studies is to evaluate different glaucoma treatments in vivo effect on the conventional outflow pathway, and specifically on the Schlemm's canal (SC) anatomy using Enhanced Depth Imaging (EDI)-optical coherence tomography (OCT) . The images will be taken as part of the patients routine medical follow up (before starting the treatment, and 1,4 and 12 weeks afterwards) diameter, cross-sectional area and volume will be measured using commercially available 3-dimensional reconstruction. The series of studies will be divided into 3 branches, each branch contains different treatments.For each treatment different patients will be recruited. The branches are as following- 1. The surgical branch- 1. Before and after trabeculotomy 2. Before and after cataract surgery 3. Before and after vitrectomy surgery 4. Before and after XEN™ Gel Stent implant 2. The pharmacological branch- 1. Before and during the treatment with prostaglandins analogs 2. Before and during the treatment with alpha blockers 3. Before and during the treatment with beta blockers 4. Before and during the treatment with carbonic anhydrase inhibitor 3. The laser branch- 1. Before and after trabeculoplasty 2. Before and after laser iridotomy 3. Before and after yag capsulotomy laser
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Optical coherence tomography imaging |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2018-05-01
- Completion
- 2018-05-01
- First posted
- 2016-06-21
- Last updated
- 2016-06-23
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02807935. Inclusion in this directory is not an endorsement.